• Andy’s CE mark expands the EU market opportunity for Amplitude Surgical

Ahmedabad :  Amplitude Surgical (Amplitude), a wholly owned subsidiary of Zydus MedTech France SAS, a wholly owned subsidiary of Zydus Lifesciences Ltd, an innovation focused life sciences company with an international presence announced that its proprietary robotic surgical system “Andy” has received CE mark approval. This confirms its compliance with European standards for safety, performance, and quality and is a milestone in orthopaedic innovation. ‘Andy’ is built with its proprietary navigation platform, Amplivision. The CE-marked solution integrates Amplitude’s navigation technology with robotic assistance, developed through a strategic collaboration with eCential Robotics.

Speaking on this development, Dr. Sharvil P. Patel, Managing Director, Zydus Lifesciences Ltd., said, “This milestone reflects our commitment to innovation that is both patient-centric and future-ready. Andy represents a convergence of science, healthcare, and technology, I extend my heartfelt congratulations to the Amplitude R&D team for their unwavering dedication and scientific excellence in bringing this breakthrough to life.”

The Andy robotic surgical system marks a significant advancement in orthopaedic surgery. Conceived as a true surgical partner, Andy is [a collaborative robot built on proprietary technology capable of performing bone resections with precision and reliability. This innovation empowers surgeons with greater confidence in the operating room and sets a new benchmark for robot-assisted procedures across Europe.

Andy delivers enhanced accuracy and consistency, enabling optimal alignment while minimizing tissue trauma which is intended to result in smaller incisions, reduced pain, faster recovery, and fewer complications, ultimately enhancing knee function, shortening hospital stays, and ensuring long-term implant performance.

Earlier this year, Zydus MedtTech expanded its global presence with the strategic acquisition of Amplitude Surgical a European MedTech company specializing in high-quality lower-limb orthopaedic technologies. This acquisition strengthens Zydus MedTech’s commitment to delivering advanced, patient-focused solutions through cutting-edge research, design innovation, and precision engineering.